Physicians are being told to loosen up on glycemic control when treating certain patients with type 2 diabetes.
Aggressive glucose management has been a mainstay of diabetes treatment, intended to reduce microvascular risks such as diabetic nephropathy, neuropathy, and retinopathy. Physicians treating patients with diabetes have traditionally set a goal of achieving and keeping glycated hemoglobin (HbA1c) levels below 7.0%. But recent trials have suggested that achieving such a level may put certain patients with diabetes at risk for cardiovascular complications and mortality.
Mitka M. Guidelines Ease Up on Glycemic Control for Some Patients With Type 2 Diabetes. JAMA. 2012;307(21):2243-2244. doi:10.1001/jama.2012.5242